XBIO Price / Book | XENETIC BIOSCIENCES, INC.

XENETIC BIOSCIENCES, INC. (XBIO) Price / Book

2026-09-03: Price/Book Ratio 1.79.
2026-06-30: Price/Book Ratio 1.12.
2026-03-31: Price/Book Ratio 0.88.
2025-12-31: Price/Book Ratio 0.67.

Historical market capitalization divided by filed shareholder equity.

Available history: 2016-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	1.79
2026-06-30	1.12
2026-03-31	0.88
2025-12-31	0.67
2025-09-30	1.22
2025-06-30	1.36
2025-03-31	0.79
2024-12-31	1.02
2024-09-30	0.95
2024-06-30	0.84
2024-03-31	0.67
2023-12-31	0.54
2023-09-30	0.69
2023-06-30	0.42
2023-03-31	4.79
2022-12-31	0.32
2022-09-30	5.29
2022-06-30	7.55
2022-03-31	8.1
2021-12-31	9.43
2021-09-30	13.61
2021-06-30	17.93
2021-03-31	17.42
2020-12-31	14.6
2020-09-30	7.21
2020-06-30	4.18
2020-03-31	2.87
2019-12-31	5.07
2019-09-30	3.69
2019-06-30	9.98
2019-03-31	211.08
2018-12-31	15.56
2018-09-30	282.73
2018-06-30	360.13
2018-03-31	174.55
2017-12-31	140.37
2017-09-30	221.16
2017-06-30	250.87
2017-03-31	339.78
2016-12-31	146.34
2016-09-30	751.75
2016-06-30	861.36

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ProPhase Labs, Inc. (PRPH)	United States	$0.006B	-0.06
Processa Pharmaceuticals, Inc. (PCSA)	United States	$0.005B
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
Pulmatrix, Inc. (PULM)	United States	$0.006B
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
Dermata Therapeutics, Inc. (DRMA)	United States	$0.005B	-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)	United States	$0.005B
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)	United States	$0.004B
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63